Literature DB >> 15618735

Expression and functional characterization of human ABC transporter ABCG2 variants in insect cells.

Toshihisa Ishikawa1, Shiho Kasamatsu, Yuko Hagiwara, Hideyuki Mitomo, Ryo Kato, Yasuhiro Sumino.   

Abstract

Hitherto three variant forms of ABCG2 have been documented on the basis of their amino acid moieties (i.e., Arg, Gly, and Thr) at the position 482. In the present study, we have generated those variants of ABCG2 by site-directed mutagenesis and expressed them in Sf9 insect cells. The apparent molecular weight of the expressed ABCG2 variants was 130,000 under non-reductive conditions, whereas it was reduced to 65, 000 by treatment with mercaptoethanol. It is suggested that ABCG2 exists in the plasma membrane of Sf9 cells as a homodimer bound through cysteinyl disulfide bond(s). Both ATPase activity and drug transport of ABCG2 variants were examined by using plasma membrane fractions prepared from ABCG2-overexpressing Sf9 cells. The ATPase activity of the plasma membrane expressing ABCG2 (Gly-482) was significantly enhanced by prazosin. In contrast, ABCG2 (Arg-482) transports [(3)H]methotrexate in an ATP-dependent manner; however, no transport activity was observed with the other variants (Gly-482 and Thr-482). It is strongly suggested that the amino acid moiety at the position of 482 is critical for the substrate specificity of ABCG2.

Entities:  

Year:  2003        PMID: 15618735     DOI: 10.2133/dmpk.18.194

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  6 in total

Review 1.  Pharmacogenomics of the human ABC transporter ABCG2: from functional evaluation to drug molecular design.

Authors:  Toshihisa Ishikawa; Ai Tamura; Hikaru Saito; Kanako Wakabayashi; Hiroshi Nakagawa
Journal:  Naturwissenschaften       Date:  2005-10

2.  The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding.

Authors:  Karin F K Ejendal; Ndeye Khady Diop; Linda C Schweiger; Christine A Hrycyna
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

Review 3.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

4.  Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.

Authors:  Yue-xian Hou; Chang-Zhong Li; Kanagaraj Palaniyandi; Paul M Magtibay; Laszlo Homolya; Balazs Sarkadi; Xiu-bao Chang
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

5.  Computational analysis and predictive modeling of polymorph descriptors.

Authors:  Yugyung Lee; Sourav Jana; Gayathri Acharya; Chi H Lee
Journal:  Chem Cent J       Date:  2013-02-04       Impact factor: 4.215

6.  Glutathione-conjugated sulfanylalkanols are substrates for ABCC11 and γ-glutamyl transferase 1: a potential new pathway for the formation of odorant precursors in the apocrine sweat gland.

Authors:  Tim Baumann; Sophia Bergmann; Thomas Schmidt-Rose; Heiner Max; Annette Martin; Bernd Enthaler; Lara Terstegen; Dorothea Schweiger; Hubert Kalbacher; Horst Wenck; Gabriele Jedlitschky; Zorica Jovanovic
Journal:  Exp Dermatol       Date:  2014-04       Impact factor: 3.960

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.